342 related articles for article (PubMed ID: 19143838)
1. Crystal structure of the parasite inhibitor chagasin in complex with papain allows identification of structural requirements for broad reactivity and specificity determinants for target proteases.
Redzynia I; Ljunggren A; Bujacz A; Abrahamson M; Jaskolski M; Bujacz G
FEBS J; 2009 Feb; 276(3):793-806. PubMed ID: 19143838
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease.
Ljunggren A; Redzynia I; Alvarez-Fernandez M; Abrahamson M; Mort JS; Krupa JC; Jaskolski M; Bujacz G
J Mol Biol; 2007 Aug; 371(1):137-53. PubMed ID: 17561110
[TBL] [Abstract][Full Text] [Related]
3. Solution structure and backbone dynamics of the Trypanosoma cruzi cysteine protease inhibitor chagasin.
Salmon D; do Aido-Machado R; Diehl A; Leidert M; Schmetzer O; de A Lima AP; Scharfstein J; Oschkinat H; Pires JR
J Mol Biol; 2006 Apr; 357(5):1511-21. PubMed ID: 16490204
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of chagasin, the endogenous cysteine-protease inhibitor from Trypanosoma cruzi.
Figueiredo da Silva AA; de Carvalho Vieira L; Krieger MA; Goldenberg S; Zanchin NI; Guimarães BG
J Struct Biol; 2007 Feb; 157(2):416-23. PubMed ID: 17011790
[TBL] [Abstract][Full Text] [Related]
5. Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi.
Monteiro AC; Abrahamson M; Lima AP; Vannier-Santos MA; Scharfstein J
J Cell Sci; 2001 Nov; 114(Pt 21):3933-42. PubMed ID: 11719560
[TBL] [Abstract][Full Text] [Related]
6. Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells.
Santos CC; Sant'anna C; Terres A; Cunha-e-Silva NL; Scharfstein J; de A Lima AP
J Cell Sci; 2005 Mar; 118(Pt 5):901-15. PubMed ID: 15713748
[TBL] [Abstract][Full Text] [Related]
7. Natural cysteine protease inhibitors in protozoa: Fifteen years of the chagasin family.
Costa TF; Lima AP
Biochimie; 2016 Mar; 122():197-207. PubMed ID: 26546840
[TBL] [Abstract][Full Text] [Related]
8. Sequence conservation in the chagasin family suggests a common trend in cysteine proteinase binding by unrelated protein inhibitors.
Rigden DJ; Mosolov VV; Galperin MY
Protein Sci; 2002 Aug; 11(8):1971-7. PubMed ID: 12142451
[TBL] [Abstract][Full Text] [Related]
9. In Silico Analysis of Homologous Heterodimers of Cruzipain-Chagasin from Structural Models Built by Homology.
Reyes-Espinosa F; Juárez-Saldivar A; Palos I; Herrera-Mayorga V; García-Pérez C; Rivera G
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875920
[TBL] [Abstract][Full Text] [Related]
10. Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin B.
Redzynia I; Ljunggren A; Abrahamson M; Mort JS; Krupa JC; Jaskolski M; Bujacz G
J Biol Chem; 2008 Aug; 283(33):22815-25. PubMed ID: 18515357
[TBL] [Abstract][Full Text] [Related]
11. The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family.
Wang SX; Pandey KC; Scharfstein J; Whisstock J; Huang RK; Jacobelli J; Fletterick RJ; Rosenthal PJ; Abrahamson M; Brinen LS; Rossi A; Sali A; McKerrow JH
Structure; 2007 May; 15(5):535-43. PubMed ID: 17502099
[TBL] [Abstract][Full Text] [Related]
12. The role of conserved residues of chagasin in the inhibition of cysteine peptidases.
dos Reis FC; Smith BO; Santos CC; Costa TF; Scharfstein J; Coombs GH; Mottram JC; Lima AP
FEBS Lett; 2008 Feb; 582(4):485-90. PubMed ID: 18201565
[TBL] [Abstract][Full Text] [Related]
13. Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
Lalmanach G; Mayer R; Serveau C; Scharfstein J; Gauthier F
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):395-9. PubMed ID: 8809025
[TBL] [Abstract][Full Text] [Related]
14. Cryptostatin, a chagasin-family cysteine protease inhibitor of Cryptosporidium parvum.
Kang JM; Ju HL; Yu JR; Sohn WM; Na BK
Parasitology; 2012 Jul; 139(8):1029-37. PubMed ID: 22444160
[TBL] [Abstract][Full Text] [Related]
15. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.
Lima AP; dos Reis FC; Serveau C; Lalmanach G; Juliano L; Ménard R; Vernet T; Thomas DY; Storer AC; Scharfstein J
Mol Biochem Parasitol; 2001 Apr; 114(1):41-52. PubMed ID: 11356512
[TBL] [Abstract][Full Text] [Related]
16. The protease inhibitor chagasin of Trypanosoma cruzi adopts an immunoglobulin-type fold and may have arisen by horizontal gene transfer.
Rigden DJ; Monteiro AC; Grossi de Sá MF
FEBS Lett; 2001 Aug; 504(1-2):41-4. PubMed ID: 11522293
[TBL] [Abstract][Full Text] [Related]
17. The crystal structure of cruzain: a therapeutic target for Chagas' disease.
McGrath ME; Eakin AE; Engel JC; McKerrow JH; Craik CS; Fletterick RJ
J Mol Biol; 1995 Mar; 247(2):251-9. PubMed ID: 7707373
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors.
Serveau C; Lalmanach G; Juliano MA; Scharfstein J; Juliano L; Gauthier F
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):951-6. PubMed ID: 8611180
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium.
Hansen G; Heitmann A; Witt T; Li H; Jiang H; Shen X; Heussler VT; Rennenberg A; Hilgenfeld R
Structure; 2011 Jul; 19(7):919-29. PubMed ID: 21742259
[TBL] [Abstract][Full Text] [Related]
20. Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites.
LaLonde JM; Zhao B; Smith WW; Janson CA; DesJarlais RL; Tomaszek TA; Carr TJ; Thompson SK; Oh HJ; Yamashita DS; Veber DF; Abdel-Meguid SS
J Med Chem; 1998 Nov; 41(23):4567-76. PubMed ID: 9804696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
